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Deregulation of the normal cellular processes that
mediate cell proliferation, differentiation and death
programs, have been seeing in various tumor cell types
[1]. Notch signaling pathway that plays fundamental
roles in definition of the cell fate and self-renewal is fre-
quently deregulated in human malignancies, by up or
down regulation, where it may act either as an oncogene
or as a tumor suppressor depending on the cell context
[2,3]. The MAML proteins are transcriptional co-activa-
tors of notch signalling that are not only essential for
related responses, but also have some regulatory func-
tions in other signaling pathways, including p53 and
Wnt/beta-catenin, and therefore have a central role in
signaling cross talk of diverse cellular processes such as
cell proliferation, differentiation and survival [4].
In current study, the expression of MAML-1 and
EGFR genes were analyzed in 44 esophageal squamous
cell carcinoma (ESCC) patients with the quantitative
(real-time) RT-PCR. Overexpression of these genes was
found in 45.5% and 38.6% of ESCC samples respectively.
Relative expression of MAML-1 was significantly asso-
ciated with the lymph node metastasis of tumor cells
(P < 0.05).
Since MAML-1 is an essential transcription coactiva-
tor of notch signaling pathway and downstream related
genes expression, we extrapolated that, notch signaling
may contribute in tumor development and metastasis in
ESCC, however further studies are required. We report
for the first time that MAML-1 gene is overexpressed as
a metastasis-related gene in ESCC samples. This indi-
cates that MAML-1 may be a possible metastatic marker
of ESCC and a possible good therapeutic target in order
to block tumor cell metastasis.
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